Welcome to our Car-T-MHC/KO therapy evaluation platform. We are dedicated to providing a safer and more effective assessment environment for Car-T cell therapies.
Platform Features and Applications:
• MHC Knockout Mouse Model: We utilize the MHC knockout mouse model to create a specific evaluation environment for Car-T cell therapies. This model is designed to mimic the actual response of Car-T cells in the human body.
• Effective Reduction of GVHD: By using the MHC knockout mice, we effectively reduce the GVHD (Graft-Versus-Host Disease) generated by Car-T cells towards the mice, offering a safer setting for your research.
• Extended Experiment Window: The reduced risk of GVHD not only enhances the safety of the experiments but also allows for an extended observation window. This ensures a more accurate assessment of the efficacy and durability of Car-T treatments.
Our Car-T-MHC/KO therapy evaluation platform lays a solid foundation for your cell therapy research and product development endeavors. Should you have any questions or require further insights, please don't hesitate to contact us.

• Using B-NDG B2M KO mice, no GVHD reaction observed. 
• Up to 10 weeks of observation time, effectively validating the long-term efficacy of cell immunotherapy. 
• Effectively observe the entire lifecycle changes of CAR cells.